Intelligent Investor

Anatara Lifesciences Ltd (ASX: ANR) - Announcements

Current share price for ANR : $0.047 0.001 (2.08%)

ASX company news and announcements for Anatara Lifesciences Ltd (ANR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anatara Lifesciences Ltd (ANR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anatara Lifesciences Ltd (ANR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anatara Lifesciences Ltd (ANR)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$9 ANR- Cleansing Notice 14 May 2024 1:06PM $0.039 $0.047 $0.044 risen by 20.51%
$9 Notification regarding unquoted securities - ANR 7 May 2024 11:55AM $0.049 $0.047 $0.044 fallen by 4.08%
$9 Application for quotation of securities - ANR 7 May 2024 11:39AM $0.049 $0.047 $0.044 fallen by 4.08%
$9 Proposed issue of securities - ANR 1 May 2024 10:15AM $0.048 $0.047 $0.044 fallen by 2.08%
$9 Anatara successful placement for $1.0M 1 May 2024 10:14AM $0.048 $0.047 $0.044 fallen by 2.08%
$9 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 10:08AM $0.048 $0.047 $0.044 fallen by 2.08%
$9 Trading Halt 29 Apr 2024 8:40AM $0.048 $0.047 $0.044 fallen by 2.08%
$9 Change in substantial holding 22 Apr 2024 2:53PM $0.042 $0.047 $0.044 risen by 11.90%
$9 Recruitment 5 sites for Pivotal IBS Clinical Trial Stage 2 9 Apr 2024 9:56AM $0.039 $0.047 $0.044 risen by 20.51%
$9 Recruitment for Pivotal Phase II IBS Clinical Trial Stage 2 29 Feb 2024 11:58AM $0.025 $0.047 $0.044 risen by 88%
$9 Appendix 4D & Half Year Report 31 December 2023 28 Feb 2024 11:52AM $0.022 $0.047 $0.044 risen by 113.64%
$9 Appendix 4C & Q2 FY24 Activities Report 24 Jan 2024 9:36AM $0.026 $0.047 $0.044 risen by 80.77%
$9 Cleansing Notice 18 Dec 2023 5:26PM $0.022 $0.047 $0.044 risen by 113.64%
$9 Application for quotation of securities - ANR 18 Dec 2023 5:24PM $0.022 $0.047 $0.044 risen by 113.64%
$9 Anatara finalises Entitlement Issue 18 Dec 2023 5:21PM $0.022 $0.047 $0.044 risen by 113.64%
$9 Change of Director's Interest Notice 13 Dec 2023 9:00AM $0.027 $0.047 $0.044 risen by 74.07%
$9 Change of Director's Interest Notice 12 Dec 2023 10:00AM $0.027 $0.047 $0.044 risen by 74.07%
$9 Cleansing Notice 11 Dec 2023 4:56PM $0.027 $0.047 $0.044 risen by 74.07%
$9 Application for quotation of securities - ANR 11 Dec 2023 4:11PM $0.027 $0.047 $0.044 risen by 74.07%
$9 Change of Director's Interest Notice 11 Dec 2023 9:15AM $0.027 $0.047 $0.044 risen by 74.07%
$9 Change of Director's Interest Notice 11 Dec 2023 9:14AM $0.027 $0.047 $0.044 risen by 74.07%
$9 Application for quotation of securities - ANR 8 Dec 2023 11:05AM $0.026 $0.047 $0.044 risen by 80.77%
$9 Entitlement Offer Results 7 Dec 2023 9:31AM $0.027 $0.047 $0.044 risen by 74.07%
$9 Notification of cessation of securities - ANR 4 Dec 2023 4:48PM $0.027 $0.047 $0.044 risen by 74.07%
$9 Letter to Ineligible Shareholders 13 Nov 2023 4:18PM $0.029 $0.047 $0.044 risen by 62.07%

1 - 25 of 423 results

Page 1 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.